Literature DB >> 1580335

Expression of cytolytic mediators by synovial fluid lymphocytes in rheumatoid arthritis.

L H Young1, S V Joag, P Y Lin, S F Luo, L M Zheng, C C Liu, J D Young.   

Abstract

To understand the role of cytolytic lymphocytes in the pathogenesis of rheumatoid arthritis, we investigated the expression of lymphocyte cytotoxicity mediators, perforin, and serine esterases, in lymphocytes derived from the synovial fluid of 15 patients with rheumatoid arthritis. Previous work has shown that CD8+ lymphocytes that possess markers of activation appear to be present in rheumatoid arthritis (RA). By means of in situ hybridization techniques and immunohistochemical analysis, the authors show that perforin and two serine esterases (serine esterase 1/Hanukah factor/granzyme A, and serine esterase 2/granzyme B) are expressed by subpopulations of CD8+ and CD56+ lymphocytes obtained from synovial fluid. The presence of these cytotoxic mediators suggests a possible mechanism for tissue damage, and provides evidence implicating cytolytic lymphocytes in the pathogenesis of RA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1580335      PMCID: PMC1886510     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  44 in total

Review 1.  A review of current concepts on the pathogenesis of juvenile rheumatoid arthritis.

Authors:  B A Lang; A Shore
Journal:  J Rheumatol Suppl       Date:  1990-03

Review 2.  How lymphocytes kill.

Authors:  L H Young; C C Liu; S Joag; S Rafii; J D Young
Journal:  Annu Rev Med       Date:  1990       Impact factor: 13.739

Review 3.  Rheumatoid arthritis--its present and future.

Authors:  M Ziff
Journal:  J Rheumatol       Date:  1990-02       Impact factor: 4.666

Review 4.  What do anti-collagen antibodies mean?

Authors:  K Morgan
Journal:  Ann Rheum Dis       Date:  1990-01       Impact factor: 19.103

Review 5.  Mechanism of lymphocyte-mediated cytotoxicity.

Authors:  P A Henkart
Journal:  Annu Rev Immunol       Date:  1985       Impact factor: 28.527

6.  The primary structure of the lymphocyte pore-forming protein perforin: partial amino acid sequencing and determination of isoelectric point.

Authors:  P M Persechini; J D Young
Journal:  Biochem Biophys Res Commun       Date:  1988-10-31       Impact factor: 3.575

7.  Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.

Authors:  T Hercend; J D Griffin; A Bensussan; R E Schmidt; M A Edson; A Brennan; C Murray; J F Daley; S F Schlossman; J Ritz
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

8.  Solubilization and characterization of a lactogenic receptor from human placental chorion membranes.

Authors:  C J Ormandy; C L Clarke; R L Sutherland
Journal:  J Cell Biochem       Date:  1990-05       Impact factor: 4.429

9.  Molecular cloning of an inducible serine esterase gene from human cytotoxic lymphocytes.

Authors:  J A Trapani; J L Klein; P C White; B Dupont
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

10.  Characterization of the natural killer-like lymphocytes in rheumatoid synovial fluid.

Authors:  M Goto; N J Zvaifler
Journal:  J Immunol       Date:  1985-03       Impact factor: 5.422

View more
  9 in total

1.  Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis.

Authors:  Violeta Romero; Justyna Fert-Bober; Peter A Nigrovic; Erika Darrah; Uzma J Haque; David M Lee; Jennifer van Eyk; Antony Rosen; Felipe Andrade
Journal:  Sci Transl Med       Date:  2013-10-30       Impact factor: 17.956

2.  Comparative susceptibility of peripheral blood leucocytes and related cell lines to killing by T-cell perforin.

Authors:  J Jones; B P Morgan
Journal:  Immunology       Date:  1994-08       Impact factor: 7.397

3.  The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA).

Authors:  P P Tak; L Spaeny-Dekking; M C Kraan; F C Breedveld; C J Froelich; C E Hack
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

4.  Localization and identification of granzymes A and B-expressing cells in normal human lymphoid tissue and peripheral blood.

Authors:  J A Kummer; A M Kamp; T M Tadema; W Vos; C J Meijer; C E Hack
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

5.  Raised granzyme B levels are associated with erosions in patients with early rheumatoid factor positive rheumatoid arthritis.

Authors:  R Goldbach-Mansky; S Suson; R Wesley; C E Hack; H S El-Gabalawy; P P Tak
Journal:  Ann Rheum Dis       Date:  2004-10-07       Impact factor: 19.103

Review 6.  Insights into the study and origin of the citrullinome in rheumatoid arthritis.

Authors:  Justyna Fert-Bober; Erika Darrah; Felipe Andrade
Journal:  Immunol Rev       Date:  2019-12-25       Impact factor: 12.988

7.  Granzyme B cleaves decorin, biglycan and soluble betaglycan, releasing active transforming growth factor-β1.

Authors:  Wendy A Boivin; Marlo Shackleford; Amanda Vanden Hoek; Hongyan Zhao; Tillie L Hackett; Darryl A Knight; David J Granville
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

8.  Serpina3n accelerates tissue repair in a diabetic mouse model of delayed wound healing.

Authors:  I Hsu; L G Parkinson; Y Shen; A Toro; T Brown; H Zhao; R C Bleackley; D J Granville
Journal:  Cell Death Dis       Date:  2014-10-09       Impact factor: 8.469

Review 9.  Intracellular versus extracellular granzyme B in immunity and disease: challenging the dogma.

Authors:  Wendy Anne Boivin; Dawn Michelle Cooper; Paul Ryan Hiebert; David James Granville
Journal:  Lab Invest       Date:  2009-09-21       Impact factor: 5.502

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.